Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor 1Carcinoma, Non-Small-Cell Lung 1

Interventions

vistusertib 2toripalimab 1tislelizumab 1tanespimycin 1sargramostim 1roniciclib 1abemaciclib 1Letrozole 1Ipilimumab 1Hydroxychloroquine 1Fulvestrant 1Anastrozole 1Albumin-Bound Paclitaxel 1AMG 337 14-toluenesulfonamide 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Solid Tumor × roniciclib × Clear all
NCT02656849 2016-07-01

BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors

Dana-Farber Cancer Institute

Phase 2 Withdrawn
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡